Abstract: Embodiments herein are directed to a transparent steering wheel system for a vehicle that includes a sensor system, a projection system, and an electronic control unit. The electronic control unit is configured to determine when a plurality of display data displayed on a display device behind a steering wheel is blocked by the steering wheel from a field of view of a driver, determine when a desirable notification is included in the plurality of display data, and when the desirable notification is included and the field of view of the desirable notification for the driver is blocked by the steering wheel, control the projection system to project the desirable notification onto the projection surface of the steering wheel that fully covers the steering wheel such that the steering wheel appears to be transparent when the desirable notification is displayed onto the projection surface.

Abstract: Certain embodiments of the present disclosure provide techniques for eliminating an appearance of one or more objects in an environment surrounding a vehicle during operation of the vehicle. A method generally includes detecting the one or more objects in first sensor data collected from first sensors onboard the vehicle, wherein the first sensor data is representative of the environment surrounding the vehicle; receiving, from other vehicles, second sensor data collected from second sensors onboard the other vehicles, wherein the second sensor data is representative of the environment surrounding each of the one or more other vehicles; generating one or more augmented reality images depicting portions of the environment obstructed by the one or more objects in the first sensor data; displaying the one or more augmented reality images in an augmented reality display such that the augmented reality images are positioned to overlay the one or more objects.

Abstract: Methods for the treatment of cardiac hypertrophy are described. Additionally, the presently disclosed subject matter relates to the use of small molecule compounds for the inhibition of Human antigen R (HuR)-mRNA interaction, and more particularly for the reduction nuclear factor of activated T cells (NFAT) transcriptional activity. Novel methods of screening for small molecule compounds for inhibition of RNA binding proteins interaction with their target RNA (such as HuR-mRNA interactions) or for inhibition of DNA binding proteins to their target DNA are also described.